US Biotech LB Pharmaceuticals Breaks 2025 IPO Drought with Strong Funding
US-based biotech company LB Pharmaceuticals has successfully raised significant funds through an initial public offering (IPO), breaking a dry spell […]
Pharmaceutical News
New Study Shows Long-Term Benefits of Eptinezumab for Chronic Migraine Patients
Lundbeck, a pharmaceutical company, shared new research about eptinezumab at the 2025 International Headache Congress in São Paulo. The data
Pharmaceutical News
New System Helps Check Tablet Quality During Manufacturing
A team of researchers in Japan has developed a new way to check the quality of medicine tablets as they
New FDA-Approved Autoinjector for Alzheimer’s Treatment Offers Convenient Option
Eisai and Biogen have received FDA approval for LEQEMBI IQLIK (lecanemab-irmb), a new autoinjector for maintaining treatment in early Alzheimer’s
Biotech Investor Otello Stampacchia on Industry Challenges and Future Outlook
Otello Stampacchia, a seasoned biotech investor, has seen the industry face many tough times over the past 20 years. He
New Startup Braveheart Bio Licenses Chinese Heart Drug for Global Development
A new pharmaceutical startup called Braveheart Bio has just acquired the rights to a promising heart medication originally developed in
FDA Reconsiders Rare Disease Drug, Setting Precedent for Future Treatments
A debate between Stealth BioTherapeutics and the FDA over a drug for Barth syndrome—a rare, often fatal childhood disease—could set
Pharmaceutical News
Gilead Builds AI-Powered US Manufacturing Hub to Boost Drug Innovation
Gilead Sciences has started construction on a new high-tech manufacturing center in the Bay Area, a key part of its
EMA Warns of Dangerous Fake Weight Loss Drugs Flooding the Market
The European Medicines Agency (EMA) has issued a serious warning about a sharp rise in illegal weight loss drugs being
Upcoming Advisory Meeting to Discuss COVID and Other Vaccines Amid Policy Changes
A recent government notice confirmed the dates for an important meeting where experts will discuss and possibly vote on recommendations